GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 105 filers reported holding GENMARK DIAGNOSTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $676,000 | -35.4% | 105,960 | -44.9% | 0.00% | 0.0% |
| Q1 2018 | $1,046,000 | -85.4% | 192,208 | -88.8% | 0.00% | -85.7% |
| Q4 2017 | $7,155,000 | -79.2% | 1,715,764 | -51.9% | 0.01% | -80.0% |
| Q3 2017 | $34,350,000 | -18.0% | 3,567,001 | +0.7% | 0.04% | -20.5% |
| Q2 2017 | $41,899,000 | +5.5% | 3,541,747 | +14.3% | 0.04% | +2.3% |
| Q1 2017 | $39,726,000 | +0.7% | 3,098,742 | -3.8% | 0.04% | -2.3% |
| Q4 2016 | $39,446,000 | +16.1% | 3,222,716 | +11.9% | 0.04% | +18.9% |
| Q3 2016 | $33,990,000 | +27.9% | 2,880,503 | -5.7% | 0.04% | +27.6% |
| Q2 2016 | $26,568,000 | +56.3% | 3,053,740 | -5.3% | 0.03% | +61.1% |
| Q1 2016 | $16,994,000 | -30.4% | 3,224,594 | +2.5% | 0.02% | -25.0% |
| Q4 2015 | $24,401,000 | +5.8% | 3,144,434 | +7.3% | 0.02% | 0.0% |
| Q3 2015 | $23,056,000 | -15.4% | 2,929,612 | -2.7% | 0.02% | -4.0% |
| Q2 2015 | $27,269,000 | -42.9% | 3,009,825 | -18.2% | 0.02% | -43.2% |
| Q1 2015 | $47,758,000 | -5.1% | 3,679,317 | -0.5% | 0.04% | -6.4% |
| Q4 2014 | $50,344,000 | +49.2% | 3,699,048 | -1.7% | 0.05% | +51.6% |
| Q3 2014 | $33,737,000 | -32.1% | 3,761,133 | +2.4% | 0.03% | -32.6% |
| Q2 2014 | $49,717,000 | +22.5% | 3,674,552 | -10.0% | 0.05% | +17.9% |
| Q1 2014 | $40,601,000 | -25.8% | 4,084,565 | -0.6% | 0.04% | -27.8% |
| Q4 2013 | $54,686,000 | +6.6% | 4,108,676 | -2.7% | 0.05% | 0.0% |
| Q3 2013 | $51,293,000 | +34.8% | 4,221,622 | +14.7% | 0.05% | +25.6% |
| Q2 2013 | $38,059,000 | – | 3,680,723 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|